Improvement of pharmaceutical potential of all-trans retinoic acid with hydroxypropyl-β-cyclodextrin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 70, Issue 3-4, 2011, Pages 389-396

  Takahashi, Keiko ^a   Morimoto, Sayo ^a   Nakamura, Hiroto ^a   Narusawa, Toshiaki ^a   Seki, Taizo ^b,d   Ooe, Masahiko ^c,d   Aoi, Keigo ^b   Takada, Akiyoshi ^c  

^a TOKYO POLYTECHNIC UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Tokiwa Pharmaceutical Co Ltd   (Japan)

Author keywords

Hydroxypropyl cyclodextrin; Inhibition of side effects; NMR; Skin rejuvenation therapy; Tretinoin

Indexed keywords

EID: 80051786587     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9857-6     Document Type: Conference Paper

References (32)

1. M Cohen 1993 Tretinoin: a review of preclinical toxicological studies Drug Dev. Res. 30 244 251 10.1002/ddr.430300407 1:CAS:528:DyaK2cXhsFars7k%3D (Pubitemid 24084452)
2. DJ Elbaum 1988 Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne J. Am. Acad. Dermatol. 19 486 491 10.1016/S0190-9622(88)70202-9 1:STN:280:DyaL1M%2FgvFShsw%3D%3D
3. L Bonhomme G Fredj S Averous AM Szekely E Ecstein B Trumbic P Meyer JM Lang J Misset C Jasmin 1991 Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid [4] Anal. Oncol. 2 234 235 1:STN:280: DyaK3M3lsFSiug%3D%3D
4. GL Fisher JJ Voorhees 1996 Molecular mechanisms of retinoid actions in skin FASEB J. 10 1002 1013 1:CAS:528:DyaK28Xks1Wntr4%3D (Pubitemid 26285976)
5. AM Kligman GL Grove R Hirose JJ Leyden 1986 Topical tretinoin for photoaged skin J. Am. Acad. Dermatol. 15 836 859 10.1016/S0190-9622(86)70242-9 1:STN:280:DyaL2s%2FjsVCltQ%3D%3D (Pubitemid 17170790)
6. SH Mandy EG Thorne 1990 A comparison of the efficacy and safety of tretinoin cream 0.025% and 0.05% Adv. Ther. 7 94 99
7. AH Lewin MG Whaley SR Parker FI Carroll CG Moreland 1982 12-Carboxyretinoic acids. Synthesis and structure J. Org. Chem. 47 1799 1807 10.1021/jo00349a001 1:CAS:528:DyaL38XhvVWnt7k%3D (Pubitemid 12039533)
8. ME Brewster T Loftsson 2007 Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 645 666 10.1016/j.addr.2007.05.012 1:CAS:528: DC%2BD2sXpsFGks7g%3D (Pubitemid 47299263)
9. T Loftsson D Duchene 2007 Cyclodextrins and their pharmaceutical applications Int. J. Pharm. 329 1 11 10.1016/j.ijpharm.2006.10.044 1:CAS:528:DC%2BD28XhtlCmtLrF (Pubitemid 44937538)
10. ME Davis ME Brewster 2004 Cyclodextrin-based pharmaceutics: past, present and future Nat. Rev. Drug Discov. 3 1023 1035 10.1038/nrd1576 1:CAS:528:DC%2BD2cXhtVarsL3P (Pubitemid 39642365)
11. K Uekama F Hirayama T Irie 1998 Cyclodextrin drug carrier systems Chem. Rev. 98 2045 2076 10.1021/cr970025p 1:CAS:528:DyaK1cXksV2itr0%3D (Pubitemid 128633447)
12. RA Rajewski VJ Stella 1996 Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery J. Pharm. Sci. 85 1142 1169 10.1021/js960075u 1:CAS:528:DyaK28XmtFKgu70%3D (Pubitemid 26372882)
13. S Gould RC Scott 2005 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review Food Chem. Toxicol. 43 1451 1459 10.1016/j.fct.2005.03.007 1:CAS:528:DC%2BD2MXmt1eiu78%3D (Pubitemid 40961909)
14. G Granero C Garnero M Longhi 2003 The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin Eur. J. Pharm. Sci. 20 285 293 10.1016/S0928-0987(03)00202-1 1:CAS:528: DC%2BD3sXosVyltrk%3D (Pubitemid 37338534)
15. B Yang J Lin Y Chen Y Liu 2009 Artemether/hydroxypropyl-β- cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode Bioorg. Med. Chem. 17 6311 6317 10.1016/j.bmc.2009.07.060 1:CAS:528:DC%2BD1MXhtVenurzN
16. RY Anadolu T Sen N Tarimc A Birol C Erdem 2004 Improved acid efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex JEADV 18 416 421 1:STN:280:DC%2BD2czms1Oqtw%3D%3D (Pubitemid 38967973)
17. D Amdidouche H Darrouzet D Duchene M-C Poelman 1989 Inclusion of retinoic acid in β-cyclodextrin Int. J. Pharm. 54 175 179 10.1016/0378-5173(89) 90338-4 1:CAS:528:DyaL1MXmtVWmsro%3D (Pubitemid 19205243)
18. P Montassier D Duchene M-C Poelman 1997 Inclusion complexes of tretinoin with cyclodextrins Int. J. Pharm. 153 199 209 10.1016/S0378-5173(97)00104-X 1:CAS:528:DyaK2sXlt1Kqurk%3D (Pubitemid 27308663)
19. P Montassier D Duchene M-C Poelman 1998 In vitro release study of tretinoin from tretinoin/cyclodextrin derivative complexes J. Incl. Phenom. Macrocycl. Chem. 31 213 218 10.1023/A:1007940722402 1:CAS:528:DyaK1cXlt1ehsLc%3D (Pubitemid 128110201)
20. Y Zhang K Liao W Liu X Ma 2002 Study on the supramolecular inclusion complex of β-cyclodextrin with retinoic acid Ind. J. Chem. 41 330 332 10.1021/ie0100737
21. SJ Seo SH Kim T Sasagawa YJ Choi T Akaike CS Cho 2004 Delivery of all trans-retinoic acid (RA) to hepatocyte cell line from RA/galactosyl α-cyclodextrin inclusion complex Eur. J. Pharm. Biopharm. 58 681 687 10.1016/j.ejpb.2004.03.025 1:CAS:528:DC%2BD2cXnvFagu74%3D (Pubitemid 39297117)
22. C Caddeo M Manconi D Valenti E Pini C Sinico 2007 Photostability and solubility improvement of β-cyclodextrin-included tretinoin J. Incl. Phenom. Macrocycl. Chem. 59 293 300 10.1007/s10847-007-9326-z 1:CAS:528:DC%2BD2sXht1OksLfF
23. D Amdidouche P Montassier M-C Poelman D Duchene 1994 Evaluation by laser Doppler velocimetry of the attenuation of tretinoin induced skin irritation by β-cyclodextrin complexation Int. J. Pharm. 111 111 116 10.1016/0378- 5173(94)00090-5 1:CAS:528:DyaK2cXntVyisLw%3D (Pubitemid 24288886)
24. WinMOPAC v3.9. Fujitsu Ltd, Tokyo, Japan (2004)
25. Stewart, J.J.P.: MOPAC2002 v.15. Fujitsu Ltd, Tokyo, Japan (2003)
26. MJS Dewar EG Zoebisch EF Healy JJP Stewart 1985 Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model J. Am. Chem. Soc. 107 3902 3909 10.1021/ja00299a024 1:CAS:528:DyaL2MXktFWlsLk%3D
27. Task force committee for evaluation of anti-aging function: Guidelines for evolution of anti-wrinkle products. J. Jpn. Cosmet. Sci. Soc. 31, 411-431 (2007)
28. U Holzgrabe R Deubner C Schollmayer B Waibel 2005 Quantitative NMR spectroscopy-applications in drug analysis J. Pharm. Biomed. Anal. 38 806 812 10.1016/j.jpba.2005.01.050 1:CAS:528:DC%2BD2MXns1WhtL8%3D (Pubitemid 41115786)
29. Lindberg, B.; Pitha, J.: European Patent 9,000,524, 1990 (Chem. Abstr. 114, 143910)
30. Szabo, T.; Szejtli, J.; Szente, L.; Horvath, G.; Peterdi, V.; Szeman, J.; Toth, A.; Komar, P.: Hungarian Patent HU, 202889, 1988
31. HJ Schneider F Hacket V Rudiger H Ikeda 1998 NMR studies of cyclodextrins and cyclodextrin complexes Chem. Rev. 98 1755 1785 10.1021/cr970019t 1:CAS:528:DyaK1cXksV2iur0%3D (Pubitemid 128633436)
32. JO Duus CH Gotfredsen K Bock 2000 Carbohydrate structural determination by NMR spectroscopy: modern methods and limitations Chem. Rev. 100 4589 4614 10.1021/cr990302n 1:CAS:528:DC%2BD3cXotVaktr0%3D (Pubitemid 32090360)